Lung Cancer Screening in High-risk Black Individuals

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Massachusetts General Hospital
Study ID
NCT05898594
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Low-dose Computed Tomography — PROCEDURE
    Per standard care

Study Details

The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose computed tomography (radiologic scan) chest scan

Key Dates

Start date
Sep 6, 2023
Status verified
Feb 2026
Primary completion
Jun 30, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
900 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Screening: Low-Dose Computed Tomography Screening
    Participants will undergo study procedures as outlined: * Complete questionnaires pre- and post- low-dose computed tomography (LDCT) test. * Visit Massachusetts General Hospital facility for a LDCT screening test.

Primary Outcome Measure

Proportion of Enrolled Participants [ Time Frame: At enrollment ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of ChicagoChicagoIllinois60637
Jessica Donington, MD
[email protected]
773-834-6121
Massachusetts General Hospital Cancer CenterBostonMassachusetts02215
Chi Fu Jeffrey Yang, MD
[email protected]
617-724-1681

Find similar trials in Chicago, IL

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of Chicago· Chicago, ILMassachusetts General Hospital Cancer Center· Boston, MA

Related Studies